Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #vital #pharma

Posted On Aug 11 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #pharmaceutical #companies

Posted On Jul 12 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


FDA Adds Three Chinese Pharma Companies to Import Alert Lists #pharma #resume

Posted On Jul 11 2017 by

#chinese pharmaceutical companies # Pharma Manufacturing FDA Adds Three Chinese Pharma Companies to Import Alert Lists More News: Join the discussion Free Subscriptions Most Popular Novartis’ Alcon Penalized $16M for Illegal Exports to Iran 2016 Contract Pharma Trends Ebook FDA OK’s Novartis Biosimilar to Amgen Arthritis Drug, Enbrel Valeant Sued for Alleged Racketeering, Linked to Philidor Novo Nordisk CEO Steps Down 2016 Contract Pharma Trends Ebook Mylan Under Fire for Huge Price Hikes on More than Just Its EpiPen Work for this Biotech Startup, Get a Free Tesla Car FDA Warns China API Maker for Hiding Quality Testing Data Innovation …


FDA Adds Three Chinese Pharma Companies to Import Alert Lists #pharma #equipment

Posted On May 17 2017 by

#chinese pharmaceutical companies # Pharma Manufacturing FDA Adds Three Chinese Pharma Companies to Import Alert Lists More News: Join the discussion Free Subscriptions Most Popular Novartis’ Alcon Penalized $16M for Illegal Exports to Iran 2016 Contract Pharma Trends Ebook FDA OK’s Novartis Biosimilar to Amgen Arthritis Drug, Enbrel Valeant Sued for Alleged Racketeering, Linked to Philidor Novo Nordisk CEO Steps Down 2016 Contract Pharma Trends Ebook Mylan Under Fire for Huge Price Hikes on More than Just Its EpiPen Work for this Biotech Startup, Get a Free Tesla Car FDA Warns China API Maker for Hiding Quality Testing Data Innovation …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #pharma #services

Posted On Apr 23 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


FDA Adds Three Chinese Pharma Companies to Import Alert Lists #purdue #pharmaceutical

Posted On Apr 21 2017 by

#chinese pharmaceutical companies # Pharma Manufacturing FDA Adds Three Chinese Pharma Companies to Import Alert Lists More News: Join the discussion Free Subscriptions Most Popular Novartis’ Alcon Penalized $16M for Illegal Exports to Iran 2016 Contract Pharma Trends Ebook FDA OK’s Novartis Biosimilar to Amgen Arthritis Drug, Enbrel Valeant Sued for Alleged Racketeering, Linked to Philidor Novo Nordisk CEO Steps Down 2016 Contract Pharma Trends Ebook Mylan Under Fire for Huge Price Hikes on More than Just Its EpiPen Work for this Biotech Startup, Get a Free Tesla Car FDA Warns China API Maker for Hiding Quality Testing Data Innovation …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #pharma #chemie

Posted On Apr 14 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


FDA Adds Three Chinese Pharma Companies to Import Alert Lists #boehringer #pharmaceuticals

Posted On Apr 12 2017 by

#chinese pharmaceutical companies # Pharma Manufacturing FDA Adds Three Chinese Pharma Companies to Import Alert Lists More News: Join the discussion Free Subscriptions Most Popular Novartis’ Alcon Penalized $16M for Illegal Exports to Iran 2016 Contract Pharma Trends Ebook FDA OK’s Novartis Biosimilar to Amgen Arthritis Drug, Enbrel Valeant Sued for Alleged Racketeering, Linked to Philidor Novo Nordisk CEO Steps Down 2016 Contract Pharma Trends Ebook Mylan Under Fire for Huge Price Hikes on More than Just Its EpiPen Work for this Biotech Startup, Get a Free Tesla Car FDA Warns China API Maker for Hiding Quality Testing Data Innovation …


Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition #mankind #pharma

Posted On Apr 6 2017 by

#azur pharma # Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition Occasionally cited as a potential takeover target, Jazz Pharmaceuticals ($JAZZ) is in the news this morning with a takeover of its own. The biotech says it has struck an all-stock deal to acquire Dublin, Ireland-based Azur Pharma, adding new CNS drugs to its list of approved drugs. Once the proposed deal goes through, the combined operation is expected to have $475 million in annual revenue. Jazz CEO Bruce Cozadd told analysts this morning that the developer–which ran into a regulatory rejection last year–has been …


FDA Adds Three Chinese Pharma Companies to Import Alert Lists #plus #pharma

Posted On Apr 5 2017 by

#chinese pharmaceutical companies # Pharma Manufacturing FDA Adds Three Chinese Pharma Companies to Import Alert Lists More News: Join the discussion Free Subscriptions Most Popular Novartis’ Alcon Penalized $16M for Illegal Exports to Iran 2016 Contract Pharma Trends Ebook FDA OK’s Novartis Biosimilar to Amgen Arthritis Drug, Enbrel Valeant Sued for Alleged Racketeering, Linked to Philidor Novo Nordisk CEO Steps Down 2016 Contract Pharma Trends Ebook Mylan Under Fire for Huge Price Hikes on More than Just Its EpiPen Work for this Biotech Startup, Get a Free Tesla Car FDA Warns China API Maker for Hiding Quality Testing Data Innovation …